logo

Quick Facts

Share SHARE

Seventy Seven Energy Inc. (SSE) posted fourth-quarter net loss of $9.4 million or $0.20 per share, narrower than $22.5 million or $0.48 per share in the comparable quarter last year. Revenues for the current quarter declined to $494.94 million from $510.85 million in the prior year period. "We...

Alere Inc. (ALR) announced it has received IVD CE marking in Europe for the Alere q HIV-1/2 Detect assay, the first molecular diagnostic at the point of care that identifies HIV-1 and HIV-2 in less than 60 minutes. "Accurate and timely diagnosis and access to anti-retroviral therapy is a matter of...

Solar module make JinkoSolar Holding Co., Ltd. (JKS) reported that fourth-quarter net income attributable to ordinary shareholders increased to RMB 244.71 million or $39.44 million, from RMB 164.29 million in the prior-year quarter. On a per share basis, the company reported earnings of RMB 0.78 or $0.13,...

Specialty healthcare company Endo International plc (ENDP, ENL.TO) Monday reported that its net loss for the fourth quarter was $53.5 million or $0.35 per share, narrower than $775.9 million or $6.74 per share in the comparable quarter last year. Adjusted net income for the latest fourth quarter rose...

Avis Budget Group, Inc. (CAR), a provider of vehicle rental services, Monday announced an agreement to acquire Maggiore Group, Italy's fourth-largest vehicle rental business, for approximately $170 million. The acquisition is expected to add approximately $160 million of annual revenue and $30 million...

Shire plc (SHPG, SHPG.L) said it has submitted a New Drug Application or NDA with the U.S. Food and Drug Administration for its investigational compound Lifitegrast for the treatment of signs and symptoms of dry eye disease in adults. The company noted that the NDA submission is supported by the totality...

Boston Scientific Corp. (BSX) announced it has entered into a definitive agreement with Endo International plc (ENDP, ENL.TO) to acquire the American Medical Systems urology portfolio, which includes the Men's Health and Prostate Health businesses, for $1.6 billion in up-front cash and a potential additional...

Gannett Co., Inc. (GCI) reported the corporate governance profile of the independent publishing company which will be spun off later in the current year as a public company operating under the Gannett name. The corporate governance profile will include: the Board will be elected annually; Special...

Intercept Pharmaceuticals, Inc. (ICPT) reported fourth-quarter net loss of $34.82 million or $1.63 per share, wider than net loss of $12.37 million or $0.64 per share in the year-ago period. On average, fourteen analysts polled by Thomson Reuters expected the company to report loss of $1.67 per share...

EV Energy Partners, L.P. (EVEP) reported fourth-quarter net income of $102.38 million or $2.03 per limited partner unit, compared to net loss of $50.19 million or $1.06 per limited partner unit last year. On average, 9 analysts polled by Thomson Reuters expected the company to report earnings of...

Akamai Technologies Inc. (AKAM) announced that it has acquired Xerocole, a provider of recursive DNS functionality, in a cash transaction. The acquisition is expected to allow Akamai to expand its DNS product portfolio beyond the Company's existing Authoritative DNS products to more completely meet...

PacWest Bancorp (PACW) agreed to acquire Square 1 Financial, Inc. (SQBK) in an all-stock deal valued at about $849 million. The deal will create a $19.8 billion asset commercial bank. The deal will see Square 1 shareholders receiving PacWest common stock based on a fixed exchange ratio of 0.5997,...

PCTEL Inc. (PCTI) announced it had acquired the assets of Nexgen Wireless, Inc., a Schaumburg, Illinois-based company providing Meridian, a network analysis tool portfolio, and engineering services. PCTEL paid $20.5 million at the closing with an additional $2 million in cash incentives for performance...

Oncolytics Biotech Inc. (ONCY, ONC.TO) said Monday that the U.S. Food and Drug Administration or FDA has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of cancer of the fallopian tube. The designation was granted on the basis of the Company's December 2014...

Alexion Pharmaceuticals Inc. (ALXN) announced that the U.S. Food and Drug Administration or FDA has accepted for Priority Review the Company's Biologics License Application or BLA for asfotase alfa, an investigational, first-in-class enzyme replacement therapy for treatment of patients with infantile-...

Follow RTT